Wang Yaxin, Wang Ziyang, Sun Yin, Yang Lin, Ma Liangkun, Li Jiao, Zhang Suhan, Yang Xuanjin
Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, PUMC Hospital, CAMS and PUMC, Beijing, People's Republic of China.
Institute of Medical Information/Medical Library, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100020, People's Republic of China.
Diabetes Metab Syndr Obes. 2024 Oct 9;17:3683-3695. doi: 10.2147/DMSO.S470863. eCollection 2024.
The study aimed to obtain more evidence on the association of gestational weight gain and pre-pregnancy body mass index (BMI) with macrosomia.
The data on 5409 live births delivered at Peking Union Medical College Hospital from July 2020 to June 2022 were collected. Group analyses were performed according to the presence or absence of macrosomia. Multivariable binary logistic regression and incidence heatmaps was used to analyze the related factors of macrosomia.
The following variables were significantly associated with macrosomia: overweight (odds ratio [OR]: 2.24, 95% confidence interval [CI]: 1.62-3.10), obesity (OR: 4.56, 95% CI: 2.93-6.98), excessive gestational weight gain (OR: 2.39, 95% CI: 1.67-3.43), gestational age at delivery at 39-41 weeks (OR: 3.83, 95% CI: 2.56-5.95), gestational age at delivery over 41 weeks (OR: 7.88, 95% CI: 4.37-14.19), education level of junior college or below (OR: 1.95, 95% CI: 1.19-3.09), and multipara (OR: 1.62, 95% CI: 1.09-2.42). "v" represents the mean weekly weight gain during the second and third trimesters. A higher v value increased the risk of macrosomia by 2.6-fold (95% CI: 1.37-4.89, P = 0.003). Compared to normal weight women, after adjustment for different pre-pregnancy BMI subgroups, overweight pregnant women had higher weekly weight gain in the second and third trimesters (OR: 4.57, 95% CI: 2.27-9.10, P < 0.001). Obese pregnant women had higher average weekly weight gain during the second and third trimesters, and the OR value for macrosomia was 11.33 (95% CI: 4.95-25.18, P < 0.001). To reduce the incidence of macrosomia in overweight pregnant women, v = 0.32 could be considered the critical threshold of average weekly weight gain in these women in the second and third trimesters of pregnancy.
Pre-pregnancy BMI and weight gain during pregnancy are closely related to macrosomia. The introduction of average weekly weight gain values in the second and third trimesters of pregnancy probably help pregnant women minimizing adverse pregnancy-related outcomes.
本研究旨在获取更多关于孕期体重增加和孕前体重指数(BMI)与巨大儿关联的证据。
收集了2020年7月至2022年6月在北京协和医院分娩的5409例活产数据。根据是否存在巨大儿进行分组分析。采用多变量二元逻辑回归和发病率热图分析巨大儿的相关因素。
以下变量与巨大儿显著相关:超重(比值比[OR]:2.24,95%置信区间[CI]:1.62 - 3.10)、肥胖(OR:4.56,95% CI:2.93 - 6.98)、孕期体重增加过多(OR:2.39,95% CI:1.67 - 3.43)、39 - 41周分娩的孕周(OR:3.83,95% CI:2.56 - 5.95)、41周以上分娩的孕周(OR:7.88,95% CI:4.37 - 14.19)、大专及以下学历(OR:1.95,95% CI:1.19 - 3.09)以及经产妇(OR:1.62,95% CI:1.09 - 2.42)。“v”代表孕中期和孕晚期的平均每周体重增加量。较高的v值使巨大儿风险增加2.6倍(95% CI:1.37 - 4.89,P = 0.003)。与体重正常的女性相比,在调整不同孕前BMI亚组后,超重孕妇在孕中期和孕晚期的每周体重增加更高(OR:4.57,95% CI:2.27 - 9.10,P < 0.001)。肥胖孕妇在孕中期和孕晚期的平均每周体重增加更高,巨大儿的OR值为11.33(95% CI:4.95 - 25.18,P < 0.001)。为降低超重孕妇巨大儿的发生率,v = 0.32可被视为这些孕妇在孕中期和孕晚期平均每周体重增加的临界阈值。
孕前BMI和孕期体重增加与巨大儿密切相关。引入孕中期和孕晚期的平均每周体重增加值可能有助于孕妇将不良妊娠相关结局降至最低。